Breaking down barriers for cancer care

For more than 25 years, we have demonstrated a strong commitment to supporting oncology patients. We have a proven track record and deep experience creating specialized programs that consider the entire patient journey, including diagnosis, disease state education, obtaining therapy and ongoing support. Our dedicated oncology care team, including a staff of benefit experts and clinicians, are specifically trained to assist with the unique challenges facing patients taking oncology therapies. 

Benefit from our expertise and partnerships:


Limited distribution therapies  


Dedicated oncology team members


Oncology care initiated by our strategic partner ION Solutions

Oncology is changing. So are we. 

Our pharmacy has been dispensing oral oncology medications since 1998 when this important therapy became an accepted treatment for cancer. As these therapies have evolved, we have tailored our processes to meet the needs of our patients as well as our manufacturer and provider partners. Our team has provided important thought leadership and insights on commercializing oncology therapies and supporting the patients who need them. 

Dedicated teams that improve access and care for oncology patients 

Oncology-specific benefits verification and patient care coordinators 

Our licensed pharmacy technicians are organized by geographic region and disease-state to provide a consistent point of contact for patients and physicians. Our regional focus supports strong, long-standing relationships with patients and regional practices as well as deep payer knowledge that helps us navigate access barriers and improve speed-to-therapy. 

Clinical care team 

Our clinical team of oncology-trained telephonic nurses and pharmacists provide expert patient education, side effect management and care planning. Our oncology-trained telephonic nurses and clinical pharmacists monitor, evaluate, counsel, document and coordinate care for patients taking oncology therapies.

Commercialization and implementation teams

Our team has deep experience supporting the commercialization and implementation of oncology therapies. We guide you from pre-launch planning to account maintenance, while providing actionable program performance reports to keep you aligned with strategic objectives.

Nationwide oncology sales team and clinical practice consultants 

Our nationwide oncology sales team is organized by region to foster well-established relationships with community-based oncologists. Working in collaboration with those sales executives to support oncology practices, our clinical practice consultants deliver additional clinical insights that promote quality and increase speed-to-therapy. 

Clinically-coordinated support for oncology patients

Acting as a conduit between the patient, their caregivers, and the oncologist, our clinicians offer oncology patients high-touch pharmacy services that are clinically-coordinated with prescribing physicians. Our US Bioservices clinicians are available 24/7 to provide clinical counseling, reporting patient side effects and associated interventions back to the physician and care team.

AmerisourceBergen Network

Our partnership with ION Solutions provides greater access to community oncologists 

Our ability to serve community-based oncologists is particularly strong through our relationship with ION Solutions, the largest GPO network of community oncologists in the country, and makes us unique among other specialty pharmacies. We work closely with ION practices to enable patient care to take place as close to the physician as possible. Our unique relationship with these prescribers positions us as a critical partner within a patient’s care team.

Achieve Gold Standard Oral Oncology Drug Adherence Through Collaboration

Oncology patients are historically among the most therapy-adherent patient populations. Recently, however, nonadherence has become an emerging challenge. Significant advancements in cancer treatment now give patients the opportunity to maintain their daily lifestyle with fewer adverse effects and better long-term disease management, but these same advancements have taken away some of the direct interaction among providers and patients that occurred when care was administered in the clinic. The greater freedom and independence that are among the advantages patients gain from oral therapies has ultimately led to lower adherence rates.